{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T10:28:47Z","timestamp":1746786527898},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00105-018-4176-8","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T10:10:29Z","timestamp":1525255829000},"page":"364-375","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Akute, lebensbedrohliche Medikamentenreaktionen der Haut","Acute life-threatening drug reactions of the skin"],"prefix":"10.1007","volume":"69","author":[{"given":"M.","family":"Mockenhaupt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"key":"4176_CR1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","volume":"138","author":"A Auquier-Dunant","year":"2002","unstructured":"Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schr\u00f6der W, Roujeau JC (2002) Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Arch Dermatol 138:1019\u20131024","journal-title":"Arch Dermatol"},{"key":"4176_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archderm.139.1.33","volume":"139","author":"N Bachot","year":"2003","unstructured":"Bachot N, Revuz J, Roujeau JC (2003) Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. A prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 139:33\u201336","journal-title":"Arch Dermatol"},{"key":"4176_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/bjd.12125","volume":"3","author":"A Barbaud","year":"2013","unstructured":"Barbaud A, Collet E, Milpied B (2013) A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol 3:555\u2013562","journal-title":"Br. J. Dermatol."},{"key":"4176_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"S Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P (2000) SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J\u00a0Invest Dermatol 115:149\u2013153","journal-title":"J Invest Dermatol"},{"key":"4176_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129:92\u201396","journal-title":"Arch Dermatol"},{"issue":"5","key":"4176_CR6","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1055\/s-0031-1299530","volume":"229","author":"A Chronopoulos","year":"2012","unstructured":"Chronopoulos A, Mockenhaupt M, Pleyer U (2012) Okul\u00e4re Beteiligung bei Stevens-Johnson-Syndrom und Toxisch epidermale Nekrolyse. Klin Monbl Augenheilkd 229(5):534\u2013539","journal-title":"Klin Monbl Augenheilkd"},{"key":"4176_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT (2004) A marker for Stevens-Johnson syndrome. Nature 428:486","journal-title":"Nature"},{"issue":"12","key":"4176_CR8","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/nm.1884","volume":"14","author":"WH Chung","year":"2008","unstructured":"Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, Chin SW, Chiou CC, Chu SC, Ho HC, Yang CH, Lu CF, Wu JY, Liao YD, Chen YT (2008) Granulysin is a\u00a0key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 14(12):1343\u20131350","journal-title":"Nat Med"},{"key":"4176_CR9","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/bjd.14530","volume":"174","author":"D Creamer","year":"2016","unstructured":"Creamer D, Walsh SA, Dziewulski P, Exton LS, Lee HY, Dart JKG, Setterfield J, Bunker CB, Ardern-Jones MA, Watson KMT, Wong GAE, Philippidou M, Vercueil A, Martin RV, Williams G, Shah M, Brown D, Williams P, Mohd Mustapa MF, Smith CH (2016) U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016. Br J Dermatol 174:1194\u20131227","journal-title":"Br J Dermatol"},{"key":"4176_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00002030-200109280-00014","volume":"15","author":"JP Fagot","year":"2001","unstructured":"Fagot JP, Mockenhaupt M, Bouwes Bavinck JN, Naldi L, Viboud C, Roujeau JC (2001) Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis\u2014preliminary results of a\u00a0case-control study. AIDS 15:1\u20136","journal-title":"AIDS"},{"issue":"15","key":"4176_CR11","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.2165\/00003495-200565150-00002","volume":"65","author":"O Faye","year":"2005","unstructured":"Faye O, Roujeau JC (2005) Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IVIG). Clinical experience to date. Drugs 65(15):2085\u20132090","journal-title":"Drugs"},{"issue":"3","key":"4176_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/tpj.2013.40","volume":"14","author":"E Genin","year":"2013","unstructured":"Genin E, Chen DP, Hung SI, Sekula P, Schumacher M, Chang PY, Tsai SH, Wu TL, Bell\u00f3n T, Tamouza R, Fortier C, Toubert A, Charron D, Hovnanian A, Wolkenstein P, Chung WH, Mockenhaupt M, Roujeau JC (2013) HLA-A*3101 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis. Pharmacogenomics 14(3):281\u2013288","journal-title":"Pharmacogenomics"},{"issue":"1","key":"4176_CR13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D397D8T291","volume":"8","author":"PD Ghislain","year":"2002","unstructured":"Ghislain PD, Roujeau JC (2002) Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online\u00a0J 8(1):5","journal-title":"Dermatol Online J"},{"key":"4176_CR14","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.jid.2017.05.022","volume":"137","author":"C Gonz\u00e1lez-Herrada","year":"2017","unstructured":"Gonz\u00e1lez-Herrada C, Rodr\u00edguez-Mart\u00edn S, Cachafeiro L, Lerma V, Gonz\u00e1lez O, Lorente JA, Rodr\u00edguez-Miguel A, Gonz\u00e1lez-Ramos J, Roustan G, Ram\u00edrez E, Bell\u00f3n T, de Abajo FJ, Working Group (2017) Ciclosporin use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches. J\u00a0Invest Dermatol 137:2092\u20132100","journal-title":"J Invest Dermatol"},{"key":"4176_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/sj.jid.5700404","volume":"126","author":"M Grosber","year":"2006","unstructured":"Grosber M, Carsin H, Leclerc F (2006) Epidermal Necrolysis in association with mycoplasma pneumoniae infection. Presented at: meeting on cutaneous adverse drug reactions and ESDR, Paris, France, 7\u20139. September 2006. J\u00a0Invest Dermatol 126:23","journal-title":"J Invest Dermatol"},{"issue":"8","key":"4176_CR16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s40264-013-0070-6","volume":"36","author":"C Haddad","year":"2013","unstructured":"Haddad C, Sidoroff A, Kardaun SH, Mockenhaupt M, Creamer D, Dunant A, Roujeau JC, RegiSCAR study group (2013) Stevens-Johnson syndrome\/toxic epidermal necrolysis: are drug dictionaries correctly informing physicians on the risk? Drug Saf 36(8):681\u2013686","journal-title":"Drug Saf"},{"issue":"1","key":"4176_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","volume":"58","author":"S Halevy","year":"2008","unstructured":"Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes Bavinck JN, Sidoroff A, Naldi L, Dunant A, Viboud C, Roujeau JC (2008) Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J\u00a0Am Acad Dermatol 58(1):25\u201332","journal-title":"J Am Acad Dermatol"},{"key":"4176_CR18","series-title":"Atlas der Hautkrankheiten","first-page":"54","volume-title":"Erythema exsudativum multiforme","author":"F Hebra von","year":"1866","unstructured":"von Hebra F (1866) Erythema exsudativum multiforme. Atlas der Hautkrankheiten, Bd. 6. Kaiserliche Akademie der Wissenschaften, Wien, S\u00a054\u201355"},{"issue":"2","key":"4176_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1365-2133.2012.10965.x","volume":"167","author":"YC Huang","year":"2012","unstructured":"Huang YC, Li YC, Chen TJ (2012) The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a\u00a0systematic review and meta-analysis. Br J Dermatol 167(2):424\u2013432","journal-title":"Br J Dermatol"},{"issue":"11","key":"4176_CR20","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"SI Hung","year":"2005","unstructured":"Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, Lin YL, Lan JL, Yang LC, Hong HS, Chen MJ, Lai PC, Wu MS, Chu CY, Wang KH, Chen CH, Fann CS, Wu JY, Chen YT (2005) HLA-B*5801 allele as a\u00a0genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S\u00a0A 102(11):4134\u20134139","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"4176_CR21","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/bjd.12133","volume":"168","author":"S Lipowicz","year":"2013","unstructured":"Lipowicz S, Sekula P, Ingen-Housz-Oro S, Liss Y, Sassolas B, Dunant A, Roujeau JC, Mockenhaupt M (2013) Prognosis of Generalized bullous fixed drug eruption: a\u00a0case control study. Br J Dermatol 168(4):726\u2013732","journal-title":"Br J Dermatol"},{"key":"4176_CR22","first-page":"106","volume":"126","author":"Y Liss","year":"2006","unstructured":"Liss Y, Mockenhaupt M, RegiSCAR-study group (2006) Erythema exsudativum multiforme majus versus Stevens-Johnson syndrome: differences in clinical pattern and etiology. J\u00a0Invest Dermatol 126:106","journal-title":"J Invest Dermatol"},{"issue":"4","key":"4176_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","volume":"6","author":"C Lonjou","year":"2006","unstructured":"Lonjou C, Thomas L, Borot N, Ledger N, de Toma C, LeLouet H, Graf E, Schumacher M, Hovnanian A, Mockenhaupt M, Roujeau JC, RegiSCAR Group (2006) A marker for Stevens-Johnson-syndrome and toxic epidermal necrolysis: ethnicity matters. Pharmacogenomics\u00a0J 6(4):265\u2013268","journal-title":"Pharmacogenomics J"},{"issue":"2","key":"4176_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","volume":"18","author":"C Lonjou","year":"2008","unstructured":"Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes-Bavinck JN, Sidoroff A, de Toma C, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M, RegiSCAR study group (2008) A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 18(2):99\u2013107","journal-title":"Pharmacogenet Genomics"},{"key":"4176_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2133.1956.tb12766.x","volume":"68","author":"A Lyell","year":"1956","unstructured":"Lyell A (1956) Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 68:355\u2013361","journal-title":"Br J Dermatol"},{"key":"4176_CR26","first-page":"390","volume-title":"Verbrennungschirurgie, Kap.\u00a036","author":"M Mockenhaupt","year":"2016","unstructured":"Mockenhaupt M (2016) Schwere blasenbildende Hautreaktionen. In: Lehnhardt M et\u00a0al (Hrsg) Verbrennungschirurgie, Kap.\u00a036. Springer, Berlin Heidelberg, S\u00a0390\u2013401"},{"key":"4176_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/978-3-642-54444-6_37","volume-title":"Verbrennungschirurgie, Kap.\u00a037","author":"M Mockenhaupt","year":"2016","unstructured":"Mockenhaupt M (2016) Das Dokumentationszentrum schwerer Hautreaktionen (dZh). In: Lehnhardt M et\u00a0al (Hrsg) Verbrennungschirurgie, Kap.\u00a037. Springer, Berlin Heidelberg, S\u00a0403\u2013416"},{"key":"4176_CR28","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/j.0022-202X.2005.23642.x","volume":"124","author":"M Mockenhaupt","year":"2005","unstructured":"Mockenhaupt M, Idzko M, Grosber M, Sch\u00f6pf E, Norgauer J (2005) Epidemilogy of staphylococcal scalded skin syndrome in Germany. J\u00a0Invest Dermatol 124:700\u2013703","journal-title":"J Invest Dermatol"},{"key":"4176_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-018-4153-2","author":"M Mockenhaupt","year":"2018","unstructured":"Mockenhaupt M, Paulmann M (2018) Schwere Hautreaktionen auf neue Medikamente. Hautarzt. https:\/\/doi.org\/10.1007\/s00105-018-4153-2","journal-title":"Hautarzt"},{"issue":"1","key":"4176_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes-Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A (2008) Stevens-johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J\u00a0Invest Dermatol 128(1):35\u201344","journal-title":"J Invest Dermatol"},{"key":"4176_CR31","unstructured":"Paulmann M, Kremmler C, Sekula P, Valeyrie-Allanore L, Naldi L, Kardaun S, Mockenhaupt M, RegiSCAR Group (2016) Long-term sequelae in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis: a\u00a05-year analysis. Allergy"},{"key":"4176_CR32","first-page":"625","volume":"13","author":"M Paulmann","year":"2015","unstructured":"Paulmann M, Mockenhaupt M (2015) Schwere arzneimittelinduzierte Hautreaktionen: Klinik, Diagnose, \u00c4tiologie und Therapie. J\u00a0Dtsch Dermatol Ges 13:625\u2013645","journal-title":"J Dtsch Dermatol Ges"},{"key":"4176_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00105-016-3850-y","volume":"68","author":"M Paulmann","year":"2017","unstructured":"Paulmann M, Mockenhaupt M (2017) Unfreiwillige Reexposition: Generalisiertes bull\u00f6ses fixes Arzneiexanthem bei 2 \u00e4lteren Patientinnen. Hautarzt 68:59\u201363","journal-title":"Hautarzt"},{"issue":"3 Suppl","key":"4176_CR34","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.jaci.2010.11.046","volume":"127","author":"EJ Phillips","year":"2011","unstructured":"Phillips EJ, Chung WH, Mockenhaupt M, Roujeau JC, Mallal SA (2011) Drug hypersensitivity: Pharmacogenetics and clinical syndromes. J\u00a0Allergy Clin Immunol 127(3 Suppl):S60\u2013S66","journal-title":"J Allergy Clin Immunol"},{"issue":"3 Suppl","key":"4176_CR35","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1016\/j.jaci.2010.11.048","volume":"127","author":"WJ Pichler","year":"2011","unstructured":"Pichler WJ, Naisbitt DJ, Park BK (2011) Immune pathomechanism of drug hypersensitivity reactions. J\u00a0Allergy Clin Immunol 127(3 Suppl):S74\u2013S81","journal-title":"J Allergy Clin Immunol"},{"key":"4176_CR36","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","volume":"333","author":"JC Roujeau","year":"1995","unstructured":"Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F, Mockenhaupt M, Paoletti C, Shapiro S, Sheir N, Sch\u00f6pf E, Kaufman DW (1995) Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N\u00a0Eng J Med 333:1600\u20131607","journal-title":"N Eng J Med"},{"key":"4176_CR37","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","volume":"49","author":"B Rzany","year":"1996","unstructured":"Rzany B, Mockenhaupt M, Baur S, Schr\u00f6der W, Stocker U, Mueller J, Holl\u00e4nder N, Bruppacher R, Sch\u00f6pf E (1996) Epidemiology of erythema exsudativum multiforme majus (EEMM), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Germany (1990\u20131992). Structure and results of a\u00a0population-based registry. J\u00a0Clin Epidemiol 49:769\u2013773","journal-title":"J Clin Epidemiol"},{"key":"4176_CR38","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/j.1365-2133.1997.tb03667.x","volume":"136","author":"TG Salopek","year":"1997","unstructured":"Salopek TG (1997) Nikolsky\u2019s sign: is it \u201edry\u201c or is it \u201ewet\u201c? Br J Dermatol 136:762\u2013767","journal-title":"Br J Dermatol"},{"issue":"1","key":"4176_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.2009.252","volume":"88","author":"B Sassolas","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K, Haustein UF, Vieluf D, Roujeau JC, Le Louet H, RegiSCAR-group (2010) ALDEN an algorithm for assessment of drug causality in Stevens-Johnson-syndrome and Toxic epidermal necrolysis. Comparison with case-control analysis. Clin Pharmacol Ther 88(1):60\u201368","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"4176_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","volume":"58","author":"J Schneck","year":"2008","unstructured":"Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M (2008) Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study. J\u00a0Am Acad Dermatol 58(1):33\u201340","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"4176_CR41","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/jid.2012.510","volume":"133","author":"P Sekula","year":"2013","unstructured":"Sekula P, Dunant A, Mockenhaupt M, Naldi L, Bouwes Bavinck JN, Halevy S, Kardaun S, Sidoroff A, Liss Y, Schumacher M, Roujeau JC, RegiSCAR-study group (2013) Comprehensive survival analysis of a\u00a0cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J\u00a0Invest Dermatol 133(5):1197\u20131204","journal-title":"J Invest Dermatol"},{"key":"4176_CR42","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archpedi.1922.04120120077005","volume":"24","author":"AM Stevens","year":"1922","unstructured":"Stevens AM, Johnson FC (1922) A new eruptive fever associated with stomatitis and ophthalmia: report of two cases in children. Am J Dis Child 24:526\u2013533","journal-title":"Am J Dis Child"},{"issue":"1","key":"4176_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00134-009-1659-1","volume":"36","author":"MF Struck","year":"2010","unstructured":"Struck MF, Hilbert P, Mockenhaupt M, Reichelt B, Steen M (2010) Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes. Intensive Care Med 36(1):22\u201332","journal-title":"Intensive Care Med"},{"issue":"5","key":"4176_CR44","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jid.2016.11.034","volume":"137","author":"SC Su","year":"2017","unstructured":"Su SC, Mockenhaupt M, Wolkenstein P, Dunant A, Le Gouvello S, Chen CB, Chosidow O, Valeyrie-Allanore L, Bellon T, Sekula P, Wang CW, Schumacher M, Kardaun SH, Hung SI, Roujeau JC, Chung WH (2017) Interleukin-15 is associated with severity and mortality in Stevens-johnson syndrome\/toxic epidermal necrolysis. J\u00a0Invest Dermatol 137(5):1065\u20131073","journal-title":"J Invest Dermatol"},{"issue":"4","key":"4176_CR45","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1365-2133.2010.09863.x","volume":"163","author":"L Valeyrie-Allanore","year":"2010","unstructured":"Valeyrie-Allanore L, Wolkenstein P, Brochard L, Ortonne N, Ma\u00eetre B, Revuz J, Bagot M, Roujeau JC (2010) Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 163(4):847\u2013853","journal-title":"Br J Dermatol"},{"issue":"4","key":"4176_CR46","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2340\/00015555-2295","volume":"96","author":"CW Yang","year":"2016","unstructured":"Yang CW, Cho YT, Chen KL, Chen YC, Song HL, Chu CY (2016) Long-term sequelae of Stevens-Johnson syndrome\/toxic epidermal necrolysis. Acta Derm Venereol 96(4):525\u2013529","journal-title":"Acta Derm Venereol"},{"key":"4176_CR47","doi-asserted-by":"crossref","unstructured":"Ziemer M, Mockenhaupt M (2011) Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy. In: Khopkar U (Hrsg) Skin biopsy. InTech-Open Access Publisher. http:\/\/www.intechopen.com\/articles\/show\/title\/severe-drug-induced-skin-reactions-clinical-pattern-diagnostics-and-therapy","DOI":"10.5772\/22335"},{"key":"4176_CR48","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1001\/archderm.143.6.711","volume":"143","author":"M Ziemer","year":"2007","unstructured":"Ziemer M, Wiesend CL, Vetter R, Weiss J, Blaschke S, Norgauer J, Mockenhaupt M (2007) Cutaneous adverse drug reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol 143:711\u2013716","journal-title":"Arch Dermatol"},{"issue":"6","key":"4176_CR49","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamadermatol.2016.5668","volume":"153","author":"S Zimmermann","year":"2017","unstructured":"Zimmermann S, Sekula P, Venhoff M, Motschall E, Knaus J, Schumacher M, Mockenhaupt M (2017) Systemic Immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol 153(6):514\u2013522. https:\/\/doi.org\/10.1001\/jamadermatol.2016.5668","journal-title":"JAMA Dermatol."}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-018-4176-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4176-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4176-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T11:03:29Z","timestamp":1693652609000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-018-4176-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["4176"],"URL":"https:\/\/doi.org\/10.1007\/s00105-018-4176-8","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"2 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Mockenhaupt gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine vom Autor durchgef\u00fchrten Studien an Menschen oder Tieren. Alle Patienten, die \u00fcber Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben. Im Falle von nicht m\u00fcndigen Patienten liegt die Einwilligung eines Erziehungsberechtigten oder des gesetzlich bestellten Betreuers vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}